China has authorized the emergency use of COVID-19 Sinovac vaccine for children aged between 3 and 17, Sinovac Chairman Yin Weidong told the media on Friday.
Sinovac confirmed to the Global Times on Friday evening that CoronaVac has been approved for emergency use for this age group. “But when the vaccine will be put into [emergency] use, and starting from what age in the group has yet to be decided,” he said.
Sinovac has finished the Phrase I and II clinical research stage, involving several hundred volunteers in this age group, which has proved that the vaccine is as safe and efficient as it is for adults, Yin told China Central Television (CCTV) in an interview on Friday.
To date, Sinovac has provided more than 600 million doses of finished and semi-finished vaccine products to nearly 40 countries and regions including China.